[
    {
        "section": "For purposes of this Section 1.2, person means mean an individual, corporation, partnership, limited partnership, limited liability company, limited liability partnership, syndicate, person (including a person as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, together with the rules and regulations promulgated thereunder), trust, association, entity or government or political subdivision, agency or instrumentality of a government.",
        "explanation": "The definition of 'person' starts with 'person means mean' which is grammatically incorrect and represents an inconsistency in the text. It should read 'person means'.",
        "location": "Section 1.2",
        "category": 3,
        "location_match": false,
        "text_match": false,
        "explanation_match": false
    },
    {
        "section": "1.33 Generic Product means, with respect to a Product and on a country-by-country basis, a product that (a) is marketed for sale in such country [***], (b) contains or comprises an antibody with the [***], (c) is approved [***], and (d) such product, as and to the extent required, is approved through an abbreviated process based in reliance, at least in part, on the safety and efficacy data generated for the prior Regulatory Approval of such Product by Aimmune or an Aimmune Agreement Entity in such country (similar, with respect to the United States, to an Abbreviated New Drug Applications under Section 505(j) of the FD&C Act (21 USC 355(j))) or is approved as a Biosimilar Biologic Product under Title VII, Subtitle A Biologics Price Competition and Innovation Act of 2009, Section 42 U.S.C. 262, Section 351 of the PHSA, or, outside the United States, in accordance with European Directive 2001/83/EC on the Community Code for medicinal products (Article 10(4) and Section 4, Part II of Annex I) and European Regulation EEC/2309/93 establishing the community procedures for the authorization and evaluation of medicinal products, each as amended, and together with all associated guidance, and any counterparts thereof or equivalent process inside or outside of the United States or EU to the foregoing.",
        "explanation": "The definition of 'Generic Product' includes bracketed information '[***]' after criteria (a), (b) and (c). This represents an omission in the legal terms as it is not clear what information is missing, and it is not clear what the criteria are for a generic product.",
        "location": "Section 1.33",
        "category": 8,
        "location_match": false,
        "text_match": false,
        "explanation_match": false
    },
    {
        "section": "1.81 Xencor Product Specific Patent means (i) the Patents identified on Schedule 1.81, including patents issuing from any patent application set forth on Schedule 1.81, (ii) with respect to all Patents set forth on Schedule 1.81, all provisional applications, substitutions, continuations- in-part, divisionals, renewals, patents-of-addition, reissues, reexaminations and extensions, (iii) any [***], and (iv) all international and domestic counterparts of any of the foregoing.",
        "explanation": "There is an omission in legal terms in section 1.81 Xencor Product Specific Patent. In part (iii) the definition states: (iii) any [***], and (iv) all international and domestic counterparts of any of the foregoing. The '[***]' signifies that information is missing and the the legal terms are not clear.",
        "location": "Section 1.81",
        "category": 8,
        "location_match": false,
        "text_match": false,
        "explanation_match": false
    }
]